Huvitz Co., Ltd
KKRX:0655106,600.00
KRW
0.00
(0.00%)
ISIN
KR7065510000
Return %
Stock
S&P 500
1Y
-24.83
14.39
3Y
-55.35
81.42
5Y
-22.63
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Hyun-Soo Kim
- Full Time Employees
- 280
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Anyang-si South Korea
- IPO Date
- Oct 31, 2003
- Website
- huvitz.com
- Similar Companies
- Business
- Huvitz Co., Ltd. is a South Korea-based medical device company engaged in the design, development, manufacture, and distribution of optometric, ophthalmic, and digital dental diagnostic and surgical systems. The company operates across three primary business divisions: Optometry and Refraction Systems, Ophthalmic Diagnostic and Lens Processing Solutions, and Digital Dentistry. Its comprehensive product portfolio comprises auto ref-keratometers, digital refractors, computerized phoropters, chart projectors, and automated lensmeters for refractive vision assessment; slit lamp microscopes, non-contact tonometers, applanation tonometers, optical biometers, and optical coherence tomography (OCT) systems integrated with fundus cameras for clinical ophthalmic diagnostics; computerized optical lens edging and blocking systems for prescription lens fabrication; and intraoral scanners, chairside milling machines, dental 3D printers, and digital dental workflow applications marketed under the Lilivis brand. The company also provides healthcare IT solutions, including the Huvitz Integrated Image Server (HIIS) for managing patient diagnostic data and clinical imaging. Huvitz serves ophthalmologists, optometrists, optical dispensaries, dental clinics, hospitals, and specialized vision care centers worldwide. The company operates globally across Asia, Europe, the Americas, and the Middle East, exporting its products to more than 110 countries through direct regional offices and established third-party distribution partnerships. Its corporate structure includes overseas operating entities such as Shanghai Huvitz Precision Device Co., Ltd. in China, alongside long-term international distribution alliances in North America and Europe. Huvitz Co., Ltd. was founded in April 1998 and is headquartered in Anyang-si, Gyeonggi-do, South Korea. In recent developments, Huvitz has accelerated strategic expansion and product portfolio diversification across both ophthalmic and dental markets. In July 2025, the company completed the acquisition of medical diagnostic device developer Ossvis, followed by the announcement of a corporate merger in August 2026 to consolidate its specialized medical imaging operations. Domestically, Huvitz established a dedicated regional branch in Daegu to expand direct commercial sales across South Korea. On the product innovation front, the company launched the HBM-1 optical biometer for cataract and myopia management in 2024; introduced the HTG-1 corneal topography and dry eye diagnostic workstation, the Lilivis SCAN intraoral scanner, and the Lilivis MILL chairside milling system in 2025; and rolled out the HPE-990 premium lens edger featuring lens-over-frame sunglass processing technology, the HVS-1 handheld vision screener, the HRKT-1 auto ref-topographer, and the HDC-100 digital visual acuity system in 2026. Additionally, the company conducted corporate capital optimization programs, executing treasury share cancellations in 2025 and 2026 to enhance shareholder value.